What is the price target for VLON stock?
7 analysts have analysed VLON and the average price target is 12.24 USD. This implies a price increase of 2960% is expected in the next year compared to the current price of 0.4.
VALLON PHARMACEUTICALS INC (VLON) Forecast, Price Target & Analyst Ratings
NASDAQ:VLON • US92023M1018
Current stock price
0.4 USD
-0.06 (-13.04%)
At close:
0.3901 USD
-0.01 (-2.48%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VALLON PHARMACEUTICALS INC (VLON).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$12.24
Upside
+ 2,960.00%
From current price of $0.40 to mean target of $12.24, Based on 7 analyst forecasts
Low
$12.12
Median
$12.24
High
$12.60
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for VLON. The average price target is 12.24 USD. This implies a price increase of 2960% is expected in the next year compared to the current price of 0.4.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
VLON was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VLON.
In the previous month the buy percentage consensus was at a similar level.
VLON was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-11-22 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 8, 2023
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 100K | -100.00% | N/A | |||
| EBITDA YoY % growth | -4.31M | -3.13M 27.38% | -4.71M -50.48% | N/A -94.78% | N/A 26.73% | |
| EBIT YoY % growth | -4.31M | -3.15M 26.91% | -4.79M -52.06% | -7.818M -93.30% | N/A 25.18% | |
| Operating Margin | N/A | N/A | -4,790.00% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.20 | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
VALLON PHARMACEUTICALS INC / VLON Forecast FAQ
What is the next earnings date for VLON stock?
VALLON PHARMACEUTICALS INC (VLON) will report earnings on 2023-05-08, before the market open.
What is the consensus rating for VLON stock?
The consensus rating for VALLON PHARMACEUTICALS INC (VLON) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.